New nasal spray aims to calm social anxiety in minutes
NCT ID NCT06615557
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 33 times
Summary
This study tests an investigational nasal spray (fasedienol) for quickly reducing anxiety during a public speaking challenge in adults with social anxiety disorder. About 236 participants will receive either the spray or a placebo, and those who complete the main study can join an open-label extension using the spray as needed for up to 12 months. The goal is to see if the spray safely eases sudden anxiety without the need for daily medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOCIAL ANXIETY DISORDER (SAD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vistagen Clinical Site
RECRUITINGPhoenix, Arizona, 85012, United States
-
Vistagen Clinical Site
ACTIVE_NOT_RECRUITINGLittle Rock, Arkansas, 72211, United States
-
Vistagen Clinical Site
RECRUITINGBellflower, California, 90706, United States
-
Vistagen Clinical Site
RECRUITINGOceanside, California, 92056, United States
-
Vistagen Clinical Site
RECRUITINGOrange, California, 92868, United States
-
Vistagen Clinical Site
ACTIVE_NOT_RECRUITINGRedlands, California, 92374, United States
-
Vistagen Clinical Site
RECRUITINGTorrance, California, 90504, United States
-
Vistagen Clinical Site
RECRUITINGDenver, Colorado, 80209, United States
-
Vistagen Clinical Site
RECRUITINGTampa, Florida, 33629, United States
-
Vistagen Clinical Site
ACTIVE_NOT_RECRUITINGDecatur, Georgia, 30030, United States
-
Vistagen Clinical Site
ACTIVE_NOT_RECRUITINGChicago, Illinois, 60640, United States
-
Vistagen Clinical Site
RECRUITINGNaperville, Illinois, 60563, United States
-
Vistagen Clinical Site
RECRUITINGBoston, Massachusetts, 02131, United States
-
Vistagen Clinical Site
TERMINATEDBloomfield Township, Michigan, 48302, United States
-
Vistagen Clinical Site
RECRUITINGFlowood, Mississippi, 39232, United States
-
Vistagen Clinical Site
ACTIVE_NOT_RECRUITINGLas Vegas, Nevada, 89119, United States
-
Vistagen Clinical Site
TERMINATEDLas Vegas, Nevada, 89121, United States
-
Vistagen Clinical Site
RECRUITINGAlbuquerque, New Mexico, 87109, United States
-
Vistagen Clinical Site
RECRUITINGNew York, New York, 10128, United States
-
Vistagen Clinical Site
TERMINATEDCincinnati, Ohio, 45229, United States
-
Vistagen Clinical Site
RECRUITINGAustin, Texas, 78737, United States
-
Vistagen Clinical Site
RECRUITINGAustin, Texas, 78759, United States
-
Vistagen Clinical Site
RECRUITINGDallas, Texas, 75251, United States
-
Vistagen Clinical Site
RECRUITINGHouston, Texas, 77055, United States
-
Vistagen Clinical Site
RECRUITINGSan Antonio, Texas, 78229, United States
-
Vistagen Clinical Site
RECRUITINGEverett, Washington, 98201, United States
Conditions
Explore the condition pages connected to this study.